"Main office in East Hartford at 144 Main Street and second location in Wallingford at 1062 Barnes Road"

During the past decade, Hartford Headache Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hartford Headache Center" #1 sponsor was "Theranica" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Alexza Pharmaceuticals, Inc." with 1 trials sponsored, "Allergan" with 1 trials sponsored and "ElectroCore INC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hartford Headache Center" #1 collaborator was "Dr. Reddy's Laboratories Limited" with 1 trials as a collaborator, "Northwell Health" with 1 trials as a collaborator, "Rambam Health Care Campus" with 1 trials as a collaborator and "Rami Burstein, PhD, Beth Israel Deaconess Medical Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hartford Headache Center" are "Migraine With Aura" (3 trials), "Migraine Without Aura" (3 trials), "Migraine" (2 trials), "Migraine Disorders" (2 trials) and "Allodynia" (1 trials). Many other conditions were trialed in "Hartford Headache Center" in a lesser frequency.

Most popular intervention types in "Hartford Headache Center" are "Drug" (5 trials), "Device" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atogepant" (1 trials), "DFN-15" (1 trials), "Dihydroergotamine" (1 trials), "Inhaled PCZ 10 mg" (1 trials) and "Inhaled PCZ 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hartford Headache Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hartford Headache Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hartford Headache Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hartford Headache Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".